Evidence map›Paper›PMID 19854676›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2009

Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.

Naoki Nozawa, June Fang-Hoover, Takako Tabata, Ekaterina Maidji, Lenore Pereira

Abstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cytomegalovirus infection and antibody protection of the developing placenta.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Naoki NozawaDepartment of Cell and Tissue Biology, University of California-San Francisco, 94122, United States.
June Fang-Hoover
Takako Tabata
Ekaterina Maidji
Lenore Pereira
University of California, San Francisco · US

Funding

Fetal HCMV Infection: Role of the Human PlacentaR01AI046657 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PEREIRA, LENORE PALMA · 2000 to 2017
$5.9M
Compensatory placental development after treatment for congenital CMV infectionR56AI073752 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PEREIRA, LENORE PALMA · 2008 to 2008
$386k
Fetal CMV Infection: Role of the Human PlacentaR56AI046657 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI PEREIRA, LENORE PALMA · 2005 to 2005
$357k
NIAID NIH HHS AI073752-01NIAID NIH HHS AI46657-09NIAID NIH HHS R01 AI046657NIAID NIH HHS R56 AI046657NIAID NIH HHS R56 AI073752
6 · The paper itself

Abstract

backgroundCytomegalovirus (CMV) is the major cause of congenital infection and disease leading to permanent birth defects. In about 35-40% of pregnant women with primary CMV infection, virus crosses the placenta, resulting in the birth of congenitally infected babies. In contrast, this happens in only 1-3% of seropositive women with strong CMV-specific humoral immunity. Whether CMV reaches the fetus and disseminates depends on the level of high-avidity antibodies in the maternal circulation and the passive immunity of the fetus. OBJECTIVES AND STUDY

designTo identify CMV infection in uncomplicated deliveries based on detection of viral DNA in placental biopsy specimens at term. To quantify CMV-specific IgG avidity, neutralizing titer, IgG1 concentration, and characterize the immunoblot profiles for CMV proteins in paired samples of placental and cord blood sera.

resultsIn accord with earlier reports, CMV DNA was detected in 39% (11/28) of placentas with mean- to high-avidity CMV-specific IgG. In seropositive women, the concentration of antiviral antibodies, specifically IgG1, increased in the fetal bloodstream, and CMV neutralizing titers in maternal and fetal blood were comparable.

conclusionsCMV-specific, high-avidity neutralizing antibodies from maternal circulation are transcytosed to the fetal bloodstream, contribute to suppression of viral replication in the placenta and could prevent congenital disease.

Indexed as

Antibodies, NeutralizingAntibodies, ViralAntibody AffinityCytomegalovirusCytomegalovirus InfectionsFemaleFetal BloodFetusHumansImmunoglobulin GInfectious Disease Transmission, VerticalNeutralization TestsPlacentaPregnancyPregnancy Complications, InfectiousAntibodies, NeutralizingAntibodies, ViralImmunoglobulin G

Identifiers

PMID19854676
PMCPMC2794836
OpenAlexW2094056567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.